PULMONARY ASPERGILLOSIS COMPLICATED WITH HAEMOPHAGOCYTIC SYNDROME SECONDARY TO CHRONIC GRANULOMATOUS DISEASE DESCRIPTION OF THE FIRST CASE

  • Hospital Universitario de los Andes Nivel Mezanina Servicio de Medicina Interna. Merida Venezuela. Correo.
  • Especialista en Medicina Interna. Facultad de Medicina. Universidad de los Andes. Merida. Venezuela.
  • Medico Internista e Intensivista Facultad de Medicina. Universidad de los Andes. Merida.Venezuela.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • How to Cite This Article
  • Corresponding Author

Chronic granulomatous disease is a primary immunodeficiency caused by mutations in the genes of the 4 subunits of NADPH oxidase. Among the clinical findings are lymphadenopathies, hepatosplenomegalies and recurrent pneumonia. It is a 16-year-old male who presents productive cough with purulent expectoration, as well as progressive dyspnea and a loss of about 10 kilos of weight in the last 3 months, at the cervical level it presents bilateral adenomegalies, cardiopulmonary rhonchi scattered without cardiac alterations, at an abdominal hepatosplenomegaly, pancytopenic is found in the admission and an image compatible with an aspergilloma is evident in the thoracic radiograph. Bone marrow aspirate was performed with positive culture for fungi compatible with Aspergillus, staining and flow cytometry were performed with confirmation of Hemophagocytosis and Chronic Granulomatous Disease. This case is exceptional because it is the first report where the 3 entities coexist in the same patient.

  1. Roos D, de Boer M. Retrotransposable genetic elements causing neutrophil defects. Eur J Clin Invest. 2018 May 17:e12953. doi: 10.1111/eci.12953.
  2. Slack MA, Thomsen IP. Prevention of Infectious Complications in Patients With?Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S25-S30. doi: 10.1093/jpids/piy016
  3. Connelly JA, Marsh R, Parikh S, Talano JA. Allogeneic Hematopoietic Cell Transplantation for?Chronic Granulomatous Disease: Controversies and State of the Art. J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S31-S39. doi: 10.1093/jpids/piy015
  4. Henrickson SE, Jongco AM, Thomsen KF, Garabedian EK, Thomsen IP. Noninfectious Manifestations and Complications of?Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S18-S24. doi: 10.1093/jpids/piy014.
  5. Rider NL, Jameson MB, Creech CB. Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of?Disease. J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S2-S5. doi: 10.1093/jpids/piy008.
  6. Bennett N, Maglione PJ, Wright BL, Zerbe C. Infectious Complications in Patients With?Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S12-S17. doi: 10.1093/jpids/piy013.
  7. Kalua K, Zimba B, Denning DW. Estimated Burden of Serious Fungal Infections in Malawi. J Fungi (Basel). 2018 May 21;4(2). pii: E61. doi: 10.3390/jof4020061.
  8. van de Peppel RJ, Visser LG, Dekkers OM, de Boer MGJ. The burden of Invasive?Aspergillosisin patients with haematological malignancy: A meta-analysis and systematic review. J Infect. 2018 Jun;76(6):550-562. doi: 10.1016/j.jinf.2018.02.012.
  9. Lee JY, Kim JH, Lee JS, Ryu JM, Seo JJ, Im HJ. Initial Characteristics and Clinical Severity of?Hemophagocytic Lymphohistiocytosisin Pediatric Patients Admitted in the Emergency Department. Pediatr Emerg Care. 2018 May 23. doi: 10.1097/PEC.0000000000001518.
  10. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, Jin M, Ji Q. Clinical significance of lymphocyte subset changes in?hemophagocytic lymphohistiocytosisof children.Exp Ther Med. 2016 Dec;12(6):3549-3552. doi: 10.3892/etm.2016.3809.
  11. Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis.Annu Rev Pathol. 2018 Jan 24;13:27-49. doi: 10.1146/annurev-pathol-020117-043625.
  12. Ochoa S, Cheng K, Fleury CM, Luccioli S, Bellanti JA. A 28-year-old woman with fever, rash, and pancytopenia. Allergy Asthma Proc. 2017 Jul 1;38(4):322-327. doi: 10.2500/aap.2017.38.4042.
  13. Wang Y, Liu D, Zhu G, Yin C, Sheng G, Zhao X. [Significance of soluble CD163 and soluble?CD25in diagnosis and treatment of children with?hemophagocytic lymphohistiocytosis]. Zhonghua Er Ke Za Zhi. 2015 Nov;53(11):824-9. Chinese
  14. Kulkarni M, Desai M, Gupta M, Dalvi A, Taur P, Terrance A, Bhat S, Manglani M, Raj R, Shah I, Madkaikar M. Clinical, Immunological, and Molecular Findings of Patients with p47<sup>phox</sup> Defect?Chronic Granulomatous Disease(CGD) in Indian Families. J Clin Immunol. 2016 Nov;36(8):774-784.
  15. Iacobini M, Duse M, Di Coste A, Balducci L. Improvement of a rapid screening test for?chronic granulomatous disease. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):807-8.
  16. Loeffert ST, Henaff L, Dupont D, Bienvenu AL, Dananche C, Cassier P, Benet T, Wallon M, Gustin MP, Vanhems P. Prospective survey of azole drug resistance among environmental and clinical isolates of?Aspergillusfumigatus in a French University hospital during major demolition works. J Mycol Med. 2018 May 28. pii: S1156-5233(17)30447-X. doi: 10.1016/j.mycmed.2018.05.007.
  17. Fernandes J, Hamidi F, Beau R, Leborgne R, Castier Y, Mordant P, Boukkerou A, Latge JP, Pretolani M. Penetration of the Human Pulmonary Epithelium by?Aspergillusfumigatus Hyphae. J Infect Dis. 2018 May 26. doi: 10.1093/infdis/jiy298.
  18. Majima S, Okachi S, Asano M, Wakahara K, Hashimoto N, Sato M, Ishigami M, Hasegawa Y. Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and?Hemophagocytic Syndrome. Intern Med. 2018 Mar 30. doi: 10.2169/internalmedicine.9673-17.
  19. Yamada A, Moritake H, Sawa D, Shimonodan H, Kojima H, Kamimura S, Nunoi H. [Refractory acute myeloid leukemia developed malignancy-associated?hemophagocyticlymphohistiocytosisduring treatment of invasive fungal infection]. RinshoKetsueki. 2013 Apr;54(4):383-7.
  20. Foley JM, Borders H, Kurt BA. A Diagnostic Dilemma: Similarity of Neuroradiological Findings in Central Nervous System?HemophagocyticLymphohistiocytosis?and?Aspergillosis. PediatrBloodCancer. 2016 Jul;63(7):1296-9. doi: 10.1002/pbc.25967.
  21. Calmettes C, Gabriel F, Blanchard E, Servant V, Bouchet S, Kabore N, Forcade E, Leroyer C, Bidet A, Latrabe V, Leguay T, Vigouroux S, Tabrizi R, Breilh D, Accoceberry I, de Lara MT, Pigneux A, Milpied N, Dumas PY. Breakthrough invasive?aspergillosisand diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis. Oncotarget. 2018 Jun 1;9(42):26724-26736. doi: 10.18632/oncotarget.25477.
  22. Bagshaw E, Enoch DA, Blackney M, Posthumus J, Kuessner D. Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK. FutureMicrobiol. 2018 Jun 18. doi: 10.2217/fmb-2018-0119.
  23. Comite Nacional de Infectolog?a; Grupo de Trabajo de Inmunolog?a. Consensus on updating immunizations in patients with?primary?immunodeficiencies. Arch Argent Pediatr. 2018 Apr 1;116(2):s20-s33. doi: 10.5546/aap.2018.s20.
  24. Duarte Ferreira R, Silva S, Carrapatoso I, Regateiro F, Santos N, Silva D, Sousa F, Oliveira S, Paiva M, Torres da Costa J, C?mara R, Faria E, Lopes da Silva S; Grupo de Interesse de Imunodefici?ncias Da Sociedade Portuguesa de Alergologia e Imunologia Cl?nica. [Letter to the Editor:?PrimaryImmunodeficiencies?in Adults - Multicentric Cooperation to Characterize the Portuguese Reality]. Acta Med Port. 2018 Apr 30;31(4):231-232. doi: 10.20344/amp.10572.
  25. Keller MD, Notarangelo LD, Malech HL. Future of Care for Patients With?Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular Medicine.J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S40-S44. doi: 10.1093/jpids/piy011.

Luis Andres Dulcey, Jonathan Antonio Pineda, Jose Jorge Sampay, Hector Alonso Moreno and Raimondo Caltagirone (2020); PULMONARY ASPERGILLOSIS COMPLICATED WITH HAEMOPHAGOCYTIC SYNDROME SECONDARY TO CHRONIC GRANULOMATOUS DISEASE DESCRIPTION OF THE FIRST CASE, Int. J. of Adv. Res., 8 (01), 1171-1175, ISSN 2320-5407. DOI URL: https://dx.doi.org/10.21474/IJAR01/10419

LUIS ANDRES DULCEY SARMIENTO
UNIVERSIDAD DE LOS ANDES MERIDA VENEZUELA

DOI:

Article DOI: 10.21474/IJAR01/10419      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10419

Download Full Paper

Download PDF No. of Downloads: 15 | No. of Views: 71